Collection of scientific works
ISSN 3083-6875 (Print)
ISSN 3083-6883 (Online)
The year of founding: 1965
The ukrainian-language edition has been published since 1998
Founder: State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of the National Academy of Medical Sciences of Ukraine» (SI «Institute of Hematology and Transfusiology of AMS of Ukraine»).
Media ID in the register of media entities-R30-04294 (Decision of the National Council of Ukraine on Television and Radio Broadcasting dated 27.06.2024 No. 2215)
Aims and Theme: Haematology & blood transfusion is a peer-reviewed scholarly interdepartamental collection aimed at presenting scientifically and practically significant research findings in the field of haematology and transfusiology, as well as at advancing professional competencies of physicians of various specialities.
Haematology & blood transfusion: interdepartamental collection publishes original research papers, exchange of experience, reviews, clinical cases and notes pertaining to a broad range of problems in the fields of haematology, haemostaseology and transfusiology. Among them are the physiology and pathophysiology of haematopoiesis, myelopoiesis, immunohaematology; conditions and diseases caused by impaired platelet function and number, congenital and acquired disorders of coagulation and fibrinolysis, thrombosis, thrombophilia; therapy; problems of oncohaematology; experimental biology and experimental therapy; epidemiological studies of blood system diseases, intensive therapy of critical conditions that arise due to various blood system diseases; issues of industrial and clinical transfusion.
UDC 616.15+615.38
Periodicity: one issue for 2 years.
Languages of the Publication: Ukrainian, English.
Scientific Publication Policy: coverage of modern achievements of domestic and foreign professionals in the field of hematology and transfusion. Informing the results of the use of the latest developments in profile medical institutions and institutions, facilitating the dissemination of scientific knowledge among the medical community.
The collection is indexed in Crossref databases, Google Scholar, Scientific Periodicals of Ukraine
The collection is included in the list of scientific professional editions of Ukraine, in which the results of the dissertation works for obtaining scientific degrees of Doctor of Sciences and Doctor of Philosophy (PhD) (category “B”; biological and medical sciences) orders of the Ministry of Education and Science of Ukraine dated 02.07.2020 № 886, 24.09.2020 №1188 with changes dated 10.12.2024 № 1721.
Publication Ethics. The editorial board of the сollection of scientific works Hematology and Blood Transfusion is committed to upholding high ethical standards in scholarly publishing. Our editorial practices are guided by the principles of objectivity, professionalism, and impartiality recognized by the global scientific community. We follow the recommendations of the Committee on Publication Ethics (COPE), the principles of academic integrity outlined in the Ethical Code of the Scientist of Ukraine, the provisions of the Law of Ukraine “On Copyright and Related Rights”, and the publication ethics policies of Elsevier (Ethics & Research in Publication – http://ethics.elsevier.com).
Editor-in-chief
Goryainova Nadiya Valeriyivna, PhD, Dr Sci (Medicine), Senior Researcher, Head of the Institute of Haematology and Transfusiology of the State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0003-2123-4140
Editorial Board Members:
Andreieva Svitlana Vasylivna, PhD, Dr Sci (Biology), Doctor of Biological Sciences, Senior Research Fellow, Senior Research Fellow at the Department of Blood Disorders of the Institute of Haematology and Transfusiology of State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0001-8748-5896
Byelinska Iryna Vasylivna, PhD, Dr Sci (Biology), Associate Professor, Department of Fundamental Medicine ESC «Institute of Biology and Medicine» Taras Shevchenko National University of Kyiv (Kyiv, Ukraine)
ORCID ID: 0000-0003-3551-1161
Belousov Andrey Nikolaevich, PhD, Dr Sci (Medicine), Associate Professor, Professor of the Department of Anesthesiology, Intensive Care and Pediatric Anesthesiology of the National Scientific Institute of Postgraduate Education, Kharkov National Medical University (Kharkov, Ukraine)
ORCID: 0000-0003-0770-8274
Bruslova Kateryna Mykhailivna, PhD, Dr Sci (Medicine), Professor, Head of the Department of Radiation-Induced Pathology Unit of Children Hematology, Institute of Clinical Radiology of State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0003-4976-0396
Grabarczyk Piotr, Ph.D, MD, Professor of Department of Virology of Institute of Hematology and Transfusion Medicine (Warsaw, Poland)
ORCID ID: 0000-0001-5200-5629
Dyagil Iryna Serhiivna, PhD, Dr Sci (Medicine), Professor, Head of the Radiation Oncohematology and Stem Cell Transplantation Department of the Institute of Clinical Radiology of the State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0001-6643-4141
Kalynychenko Tetiana Oleksiivna, PhD, Dr Sci (Medicine), Senior Researcher, Head of Laboratory of Hemopoietic Cell Cryopreservation of the Institute of Hematology and Transfusiology State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of the National Academy of Medical Sciences of Ukraine» (Kyiv, Ukraine)
ORCID ID: 0000-0002-4905-3256
Novak Vasyl Leonidovych, PhD, Dr Sci (Medicine), Corresponding Member of National Academy of Medical Sciences of Ukraine, Professor, Acting Director of State Institution «Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine» (Lviv, Ukraine)
ORCID ID: 0000-0002-5979-5018
Skrinda Ilona, PhD, Dr Sci (Biology), Head of the Laboratory of Daugavpils Regional Hospital, Head of the Blood Collection Unit (Daugavpils, Latvia)
ORCID ID: 0000-0003-3137-004X
Syvak Liubov Andriyvna, PhD, Dr Sci (Medicine), Professor, Leading Researcher Department of Radiation Oncohematology and Stem Cell Transplantation Institute of Clinical Radiology of State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0003-2261-6482
Stasyshyn Oleksandra Vasylivna, PhD, Dr Sci (Medicine), Senior Research Associate, Deputy Director for Scientific Work of the State Institution «Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine» (Lviv, Ukraine)
ORCID ID: 0000-0002-8366–5926
Shpakova Nataliia Mykhailіvna, PhD, Dr Sci (Biology), Senior Research Fellow, Head of the Cryocytology Department of the Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine (Kharkiv, Ukraine)
ORCID ID: 0000-0002-0148-7522
Executive Secretary:
Nastenko Olena Petrivna, PhD, Senior Researcher, Scientific Secretary of Institute of Haematology and Transfusiology of the State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine», (Кyiv, Ukraine)
ORCID ID: 0009-0002-8539-8355
Technical Secretary:
Bortnik Hanna Anatoliivna, Scientific Researcher at the Department of Blood Disorders of the Institute of Haematology and Transfusiology of the State Institution «National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine» (Кyiv, Ukraine)
ORCID ID: 0000-0002-7579-5579
GENERAL PROVISIONS
The сollection of scientific works Hematology and Blood Transfusion publishes peer-reviewed articles that represent completed research and contain new findings in the fields of hematology, clinical and industrial transfusiology, or reviews of the current state and pressing issues in these areas. Submitted articles must not have been previously published elsewhere.
Articles are published in Ukrainian or English.
MANUSCRIPT SUBMISSION GUIDELINES
To have an article considered for publication in the journal, authors must submit the following materials by mail or in person to the editorial office:
Electronic versions of the manuscript should be sent by email to the editorial office at: igt2@ukr.net.
The length of an original article should not exceed 12–15 pages; for a review article, 20–25 pages. A longer manuscript may be accepted on an individual basis, subject to the decision of the editorial board.
PEER REVIEW
All submitted articles undergo mandatory peer review by independent experts who are specialists in the relevant field of science.
The final decision regarding the suitability of an article for publication is made by the editorial board.
Manuscripts will not be returned to the authors.
Original copies of the articles and their reviews are retained by the editorial office for three years from the date of publication.
TECHNICAL REQUIREMENTS FOR ARTICLE TEXT
Articles must be prepared using MS Word for Windows with the following formatting: Times New Roman font, 14-point size, 1.5 line spacing, A4 paper size (210 × 297 mm). Page margins should be: top and bottom – 2 cm; left – 3 cm; right – 1 cm. Paragraph indentation should be 1.25 cm. Do not use spaces or tab characters for paragraph or heading formatting.
In numerical ranges, use only an en dash (–) with no spaces before or after the numbers.
The symbols №, %, ‰, and mathematical signs (±, ?, :, =, >, <, etc.) must be separated from numbers with a non-breaking space.
All designations and names of physical units must comply with the International System of Units (SI). If the research was conducted using instruments that provide measurements in non-SI units, these must be converted into SI units, with the original units provided in parentheses.
Disease names should follow the latest revision of the International Classification of Diseases (ICD); names of pharmaceutical substances should conform to International Nonproprietary Names (INN).
Abbreviations (in capital letters only) should be introduced in the text only after the first mention with the full phrase spelled out.
Data presented in tables should not duplicate the data from figures or the text, and vice versa.
Original research articles must contain the following clearly defined sections:
Review articles may be either unstructured or organized into sections with thematic subheadings.
ORDER OF CONTENT PRESENTATION IN THE ARTICLE:
For articles written in Ukrainian, items 2–6 must also be provided in English after item 6.
The title of the article must be as brief and informative as possible, without abbreviations or the use of commercial names of medicinal products.
Word hyphenation is not allowed in titles at any level, including table headings.
If the authors are affiliated with different institutions, a superscript number should be placed after each author’s surname to indicate the corresponding institution. The author responsible for correspondence should be marked with an asterisk (*) next to the superscript number. This author must clearly indicate whether their email address may be published with the article.
On the last page, the corresponding author should provide their full name, postal and email addresses, and telephone numbers (work or mobile) for editorial contact.
The abstract for original articles (at least 1,800 characters without spaces) must be structured as follows:
a) Objective of the study;
b) Materials and methods;
c) Results;
d) Conclusions.
Abstracts of review articles are unstructured.
Abbreviations are not permitted, except for commonly accepted ones.
Article Text
The article must be carefully edited and thoroughly reviewed by the authors. The presentation of the material should be clear, concise, and free from lengthy introductions or repetitions. Authors bear full responsibility for the content and the accuracy of the data presented in the article.
Original research articles must include the following clearly defined sections:
Review articles may be unstructured or divided into thematic sections.
Introduction
Justification of the study. Briefly outlines the general background of the problem and its connection with important scientific or practical challenges. Includes an analysis of recent studies and publications in which this problem has been initiated and which the author relies on, and identifies previously unresolved parts of the overall problem addressed in the article.
Objective of the Study
The aim or objectives of the research.
Materials and Methods
The research design and data analysis must be described briefly but clearly enough to allow replication of the study by other researchers. Reference should be made to well-established methods, a brief description and citation of published but lesser-known methods, and a detailed description of new or significantly modified methods, with justification for their use. Only new methods should be described in detail.
The names of equipment, materials, and reagents, as well as the manufacturers’ names, must be provided in the original language (without translation).
This section should clearly and in detail describe how patients for observations or animals for experiments (including control groups) were selected, including inclusion and exclusion criteria.
In experimental studies, the species, sex, and number of animals should be specified, as well as the methods of anesthesia for procedures or sample collection, materials for laboratory investigations, euthanasia methods, in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (1986) (http://zakon5.rada.gov.ua/laws/show/994_137) and the “Regulations on Conducting Scientific Research and Experiments on Animals” (Order of the Ministry of Education and Science, Youth, and Sports of Ukraine No. 249, dated 01.03.2012) (https://zakon.rada.gov.ua/laws/show/z0416-12#Text).
Clinical studies must be conducted in accordance with the “Good Clinical Practice” standards and the principles of the Helsinki Declaration of the World Medical Association, “Ethical Principles for Medical Research Involving Human Subjects” (https://zakon.rada.gov.ua/laws/show/990_005). Study participants must be informed of the purpose and key points of the research, and they must sign a written consent to participate in the study.
Authors are required to provide details of the procedure described in the study protocol and indicate that the protocol has been approved by the Medical Ethics Committee.
At the end of the “Materials and Methods” section, a subsection titled “Statistical Analysis of Data” should be included, stating which data processing methods were used by the author(s). When describing the study structure and statistical methods, the statistical package and computer programs used for statistical analysis of results, accessible to ordinary users, should be specified.
Whenever possible, the use of standard statistical methods is recommended, with references to known manuals and textbooks. For unconventional or new statistical methods, appropriate references should be provided, detailing the mathematical methods and algorithms used.
Results and Discussion
The results section should present the core findings of the study with a complete justification of the obtained scientific results.
Results should be presented in a logical sequence in the text, tables, and figures. It is not necessary to repeat the data from tables and figures in the text, but only to compare them. When summarizing quantitative data, both relative (e.g., percentages) and absolute values should be provided, and the statistical methods used for their analysis should be stated.
The discussion section should contain the interpretation of the results, not their repetition. The new and important aspects of the study findings should be highlighted, with analysis of possible mechanisms or interpretations of these data. If possible, compare the results with those of other researchers. The discussion may include well-grounded recommendations for practice and potential applications of the findings in future research.
Illustrations
Figures should be clear, and photographs should be contrasting. Figures are placed directly in the text of the article, with figure titles and captions provided below the figures. The captions should explain all curves, letters, numbers, and other symbols used. References to the main text are allowed to avoid repetition and inaccuracies. For micrographs, the magnification level and staining method should be indicated in the captions.
Figures (schemes, graphs, diagrams, photographs) can be submitted in black-and-white or color format. Graphs and diagrams should be created as Word charts or in MS Excel format. They must include all necessary labels for coordinate axes, curves, and other details.
All lines, curves, symbols, and axis labels must be depicted clearly (curve lines should be thicker than coordinate axis lines). If figures consist of multiple elements, they should be grouped accordingly.
Tables
Tables should be clear, have a title and a sequential number, and contain concise, necessary data. The units of measurement and the format for presenting data (e.g., M±m; M±SD; Mt; Mo; percentiles, etc.) must be clearly indicated. All numbers, totals, and percentages in tables must be carefully checked and correspond to references in the text. Each table must be referenced in the text. All explanations, including abbreviations, should be provided in footnotes. Table titles are placed above the tables, while footnotes are placed below them.
Conclusions
Conclusions should be formulated based on the results of solving the problem outlined in the title and the objective of the article.
Sources of Funding
All sources of funding for the research must be listed, including both direct and indirect financial support (such as the provision of equipment/materials, other forms of support). The names of the organizations that funded the research should be provided in full.
Acknowledgments
This section should acknowledge individuals, institutions, or organizations that contributed to the research and assisted in the preparation of the article.
Conflict of Interest
The article must disclose any actual or potential conflicts of interest. If there is no conflict of interest, it should be stated: “The author(s) declare(s) no conflict of interest.”
The Structuring of Reviews, Lectures, Discussion Articles, Case Observations, and Methodological Reports
The structure of reviews, lectures, discussion articles, case observations, and methodological reports can be flexible. Reviews should comply with international recommendations for systematic literature search methods, which are publicly available through PRISMA guidelines. Clinical observations should be formatted according to the CARE guidelines.
The formatting procedure for English-language articles is the same.
References
When working with information sources, preference should be given to publications from recent years. If the cited article has a DOI identifier, it must be included at the end of the reference. If the cited source does not have a DOI but is available online, the URL should be included in the reference.
References should be listed in the order in which they are mentioned in the text. In-text citations should be indicated with Arabic numerals in square brackets. The author(s) is/are responsible for the accuracy of the data presented in the reference list.
The reference list in the article should be formatted according to the Vancouver style (https://www.scribbr.co.uk/referencing/vancouver-style/) in the original language. For non-English articles, the English version of the bibliographic description should be placed in square brackets after the title.
Each source should be placed on a new line under its corresponding number, which is indicated in the text with Arabic numerals in square brackets. The maximum number of references for original articles is up to 30, and for reviews — up to 50. Avoid self-citations or minimize them. Also, try to minimize references to conference abstracts. Journal titles can be abbreviated if this is the format used on the journal’s website.
Ethical Issues
Authors submitting a manuscript to the scientific journal “Hematology and Blood Transfusion” for review must guarantee compliance with all publication ethical standards and ethical norms.
The editorial board reserves the right to conduct scientific and literary editing of the article.
Articles that do not meet the specified formatting requirements will not be considered.
After the article is accepted for publication by the editorial board, the authors will be sent a license agreement, which must be completed and signed, then submitted to the editorial office in two copies.
ОРИГІНАЛЬНІ СТАТТІ
ОГЛЯДИ ЛІТЕРАТУРИ
ОБМІН ДОСВІДОМ
КЛІНІЧНІ ВИПАДКИ
ОРИГІНАЛЬНІ СТАТТІ
ОГЛЯДИ ЛІТЕРАТУРИ
СТОРІНКИ ІСТОРІЇ
ОРИГІНАЛЬНІ СТАТТІ
ОГЛЯДИ ЛІТЕРАТУРИ
ОРИГІНАЛЬНІ СТАТТІ
КЛІНІЧНІ ВИПАДКИ
ОГЛЯДИ ЛІТЕРАТУРИ
The editorial board of the journal Hematology and Blood Transfusion adheres to high international standards of scientific publishing ethics, guided by the recommendations of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), the International Committee of Medical Journal Editors (ICMJE), as well as current Ukrainian legislation in the field of publishing.
The editorial team is committed to ensuring:
Editorial independence is guaranteed by the absence of influence from commercial, political, or other interested parties. The editorial board does not tolerate discrimination against authors or reviewers on any grounds.
Manuscript Review and Editorial Decision Process
All manuscripts submitted to the journal undergo a preliminary review by the editorial board to assess their relevance to the journal’s scope. Suitable manuscripts are then sent for peer review.
The decision to publish is made by the Editor-in-Chief and the editorial board based on a positive review and the following criteria:
While reviewer evaluations are a critical part of the decision-making process, they are not the sole determinant. Additional reviews may be requested, or clarifications sought from the authors if necessary.
If a manuscript is rejected, the author has the right to appeal the decision with a detailed justification. The manuscript may then be re-evaluated by the same or new reviewers or editors, but this does not guarantee publication.
Authors’ Responsibilities
Authors are required to:
When submitting an article, authors must declare any potential conflicts of interest that may affect the objectivity or integrity of the publication, or explicitly state the absence of such conflicts.
The corresponding author is responsible for communication with the editorial office, informing co-authors of the manuscript’s status, and confirming authorization to represent all listed authors.
Disputes concerning authorship are handled in accordance with the principles of COPE, WAME, and ICMJE. Changes in authorship are only permitted with the written consent of all authors.
Adherence to Academic Integrity
The editorial board employs measures to detect plagiarism, self-plagiarism, data fabrication, and other ethical violations. Any confirmed violations are grounds for rejection or retraction of a published article.
Grounds for retraction include:
Retraction decisions are made by the Editor-in-Chief and the editorial board based on a detailed review of the situation. A retraction notice is published openly with an explanation of the reasons.
Retraction is not applied when:
Open Access Policy and Copyright
The editorial board supports an open access policy, promoting the free dissemination of scientific information in the interest of global progress.
By submitting an article to the journal, authors agree to grant the editorial board non-exclusive rights to:
All rights and obligations of the parties are defined in a License Agreement, a sample of which is provided to the authors after a positive decision on publication.
All articles submitted to the Editorial Board of the Collection are subject to internal peer review. The review is conducted by qualified experts from the editorial board who possess appropriate qualifications and experience.
Manuscripts are sent to one reviewer, or to two if necessary. In complex cases, the decision on the selection of reviewers is made at a meeting of the editorial board.
The purpose of the review process is to prevent unethical scientific practices, ensure adherence to publication quality standards, and take into account the interests of all parties involved: authors, readers, reviewers, and the editorial team.
Peer review helps select only high-quality materials for publication and provides authors with specific recommendations for improving their articles. The procedure is based on the principles of objectivity, professional ethics, and compliance with the journal’s requirements.
Before the review, each manuscript is checked for text originality.
The review process is anonymous (double-blind): reviewers do not know the authors, and authors do not know the reviewers. All communication between parties takes place through the responsible secretary.
During the review, the following aspects are assessed:
The reviewer may recommend revisions or shortening of the manuscript, clearly indicating what needs to be changed. Comments must be specific, well-grounded, and aimed at improving the material.
The reviewer must provide their conclusion no later than 21 days after receiving the manuscript. If necessary, the timeframe may be adjusted to ensure a thorough evaluation.
After the review, the author receives the review text and may make revisions or provide a reasoned response. When submitting a revised article, the author should also include an explanation of the changes made.
The revised version is sent back to the reviewer for a final assessment. If the review is positive, the article is added to the editorial portfolio.
If the author disagrees with the reviewer’s conclusions, they have the right to submit a justified response. In such cases, the issue is reviewed by the editorial board. A repeated or new review by another expert may be conducted, following the double-blind principle.
The final decision on publication is made by the Editor-in-Chief or an authorized editorial board member. In complex cases, the entire editorial board may be involved.
The editorial board reserves the right to reject an article if the author refuses to address justified reviewer comments.
The author is notified of the article’s acceptance for publication by the responsible secretary.
© 2025 Hematology and blood transfusion